Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ANAB
ANAB News & Events
-
Add to Watchlist
Trade ANAB
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ANAB News
AnaptysBio Director Sells 3,900 Shares for $193,342.50
Jan 12 2026
NASDAQ.COM
AnaptysBio Director Sells 3,900 Shares for $193,342.50
Jan 12 2026
Fool
AnaptysBio CMO Paul Lizzul Sells 3,650 Shares for $163,191.50
Jan 11 2026
NASDAQ.COM
AnaptysBio CMO Sells 3,650 Shares for $163,191.50
Jan 11 2026
Fool
AnaptysBio Fights Tesaro Lawsuit, Seeks to Uphold Licensing Rights
Jan 09 2026
Benzinga
AnaptysBio Moves to Dismiss Tesaro's Breach Claim Ahead of July 2026 Trial
Jan 08 2026
Globenewswire
ALX Oncology Gains 10.17% on Positive Phase 2 Trial Data for Evorpacept
Jan 08 2026
NASDAQ.COM
AnaptysBio CEO Daniel Faga to Present at J.P. Morgan Healthcare Conference on January 13, 2026
Jan 06 2026
Globenewswire
Show More News
ANAB Events
No data
ANAB Monitor News
No data
ANAB Earnings Analysis
No Data
People Also Watch
